GLOBAL ACCESS

80

Countries

90%

of districts in India with secondary healthcare facilities

18K

Hospitals in India

40K

Surgeons in India

#1

in size of direct sales force amongst medical devices companies in India

*As on March 31, 2021

Who We Are

Global Medtech Company

Healthium Medtech is a global medical-technology company focused on products used in surgical, post-surgical and chronic care. Propelled by our vision to provide “Access to precision medtech for every patient, globally," we have a presence in over 80 countries. In India, we are the largest independent medical device company in the surgical consumables market (value as of Fiscal Year 2021). One in five surgeries globally, uses a Healthium product.*

1 in 5*

Surgeries conducted globally, uses a Healthium product

#1

Independent Indian Medical Devices Company in surgical consumables market

#1

Non- captive surgical needles manufacturer globally by volume

#2

Surgical consumables company in India by value .

#3

In UK in urology collection devices based on market share

*As on March 31, 2021

WHAT INSPIRES US

PRECISION DRIVEN MANUFACTURING

Integrated manufacturing facilities with global certifications

8

Manufacturing Facilities

1st

Indian Class III medical device company to receive US FDA registration for one of the manufacturing facilities

Only

CE-certified surgical needles manufacturing facility in India as on March 31, 2021

What We Deliver

GLOBALLY RECOGNIZED INNOVATION

Healthium Medtech has an innovative and comprehensive product suite driven by our focused research and development efforts. Since Fiscal year 2018, we have sold 30 new products including our patented portfolio of arthroscopy products, 1st barbed suture with a triangular stopper, & anti-microbial gloves. We hold 35 patents in U.S, Europe and India and 29 pending patent applications including CareNow (total 64 patents in U.S, Europe and India)**

30*

New products*

64*

Patents in U.S, Europe and India*

52000*

SKUs of Products*

*Since Fiscal year 2018

What Drive Us

GLOBALLY DIVERSE SENIOR MANAGEMENT

We have a diverse and inclusive work culture. A seasoned professional Leadership team with extensive industry knowledge backed by an experienced Board of Directors.

What is Trending

NEWS ROOM

Healthium acquires CareNow

Read More

Healthium acquires AbGel to strengthen portfolio and expand market presence

Read More

Healthium bags top leadership awards at World Leadership Congress and CFO100 Awards

Read More

Leading Medtech player Healthium ramps up operations to ensure critical deliveries to healthcare providers are met within 24 to 48 hours

Read More

Healthium acquires VitalCare Group in U.K. to strengthen its global urology portfolio

Read More

Healthium Medtech clocks its 3rd Innovation in 6 months with TRUSHIELD AMG - first of its kind Anti-Microbial gloves in India

Read More

HEALTHIUM MEDTECH LTD

(formerly known as Healthium Medtech Private Limited)

472/D, 13th Cross, 4th Phase, Peenya Industrial Area, Peenya Industrial Area Phase IV, Peenya, Bengaluru, Karnataka - 560 058, INDIA

CIN: U03311KA1992PLC013831

contact@healthiummedtech.com

For any queries or complaints write to
care@healthiummedtech.com

Customer care number
+91-80-41868000

DISCLAIMER

“Healthium Medtech Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India. The DRHP is available on the website of the SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, ICICI Securities Limited, CLSA India Private Limited, Credit Suisse Securities (India) Private Limited and Nomura Financial Advisory and Securities (India) Private Limited, at www.icicisecurities.com, www.india.clsa.com, www.credit-suisse.com and www.nomuraholdings.com/company/group/asia/india/index.html, respectively, and the websites of the stock exchange(s) at www.bseindia.com and www.nseindia.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see "Risk Factors" of the RHP / Prospectus, when available. Potential investors should not rely on the DRHP for any investment decision.”

We use cookies to ensure you get the best experience on our website. Click here to view cookie policy